Christopher Shaw, M.D.
Professor Chris Shaw conducted his clinical training in general medicine and neurology in New Zealand. In 1992, he began his doctoral studies on Wellcome Trust Fellowship with Professor Alastair Compston at the University of Cambridge. Research led by Chris has identified mutations in two genes causing ALS, namely TARDBP and FUS. Chris is Professor of Neurology and Neurogenetics at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. His major research interest is in the genetic, molecular and cellular basis of motor neuron diseases such as amyotrophic lateral sclerosis (ALS). He is also Head of the Department of Basic and Clinical Neuroscience, Director of the Maurice Wohl Clinical Neuroscience Institute at King’s College London and an Honorary Consultant Neurologist and Neurogeneticist at King’s College Hospital.